Buy NAD+ Injection: Sterility Is the Whole Question
Summary: An injectable is judged on how it was made rather than on what is in it, and NAD+ is the one compound on this site where the regulator has already published what goes wrong when that distinction is ignored.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
If you set out to buy NAD+ injection material, you are not choosing between brands. You are choosing between three formats that differ almost entirely in who took responsibility for sterility, and that is the variable worth spending your attention on.
Where readers actually buy it
Ascension Peptides — NAD+
Research-grade NAD+, tested by two outside labs and shipped from the US. The code below takes half off the vial.
Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Batch certificates from two independent labs
- Free shipping over $250
- Ships same day if ordered before 2pm CST
Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 20, 2026.
Most purchase pages in this niche treat the format as a detail and the price as the decision. That is backwards here. NAD+ is the one compound covered on this site where the regulator has already published, in plain language, what happens when the sterility question is skipped.
NAD+ is a coenzyme, and this reader is usually on a GLP-1
Before the formats, the correction that most of this market gets wrong. NAD+ is not a peptide. Nicotinamide adenine dinucleotide is a coenzyme, a small helper molecule your cells build and consume continuously while moving electrons through energy metabolism. It is also not a GLP-1, not an incretin, and not a weight-loss medicine, so it does not belong in the same comparison as the drugs this site normally covers.
The reason a GLP-1 reader ends up here is fatigue. Eating in a sustained deficit is tiring, NAD+ has been marketed at tiredness for years, and injectables feel more serious than capsules. Before you treat that feeling as evidence, our page on how long GLP-1 fatigue lasts covers the explanations that are cheaper to test. On the evidence itself, a 2026 PRISMA-guided systematic review of NAD-related interventions found that oral precursors reliably shifted NAD-related metabolites in blood, that outcome effects were heterogeneous and often null, and that no eligible outcomes trials evaluated intravenous or intramuscular NAD+ itself for anti-aging or wellness indications [4]. That is not proof of nothing. It is an absence of the trials people assume exist.
Buy NAD+ injection: three formats, one bar to clear
| Format | What you actually receive | Who is responsible for sterility | What testing normally exists |
|---|---|---|---|
| Clinic IV, the drip bar route | A finished, compounded intravenous product administered on site | The compounding pharmacy that prepared it, and the clinic administering it | Whatever the pharmacy performed, which the clinic can tell you if you ask |
| Compounded vial on a prescription | A finished sterile preparation dispensed to a named patient | The 503A pharmacy or outsourcing facility that compounded it | Compounding standards apply, including requirements on the incoming bulk substance |
| Research vial shipped to you | Lyophilised NAD+ powder sold for laboratory research and not for human use | Nobody. The seller has expressly disclaimed the use | Whatever the seller publishes on the certificate of analysis, which varies enormously |
That table is the entire page in one block. The sterility bar is highest for injectables and the responsibility for clearing it falls away completely in the third row, which is also the row where buying is easiest, cheapest and most casual. Somebody buying a NAD+ shot from a search result at midnight is buying from the column with no one in it.
The FDA notice this page is built around
In a compounding notice with content current as of 30 October 2024, the FDA wrote that it "is aware of compounders using food-grade nicotinamide adenine dinucleotide (NAD+) sold by repackagers to make intravenous products", and that "ingredients identified as food grade are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins". It went on: "FDA has received adverse event reports following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue with some requiring medical treatment. These reactions are consistent with excessive levels of endotoxins." [1]
Read that carefully, because it is unusually specific. It is not a general warning about research chemicals. It names this substance, this route, this failure mode, and the symptom pattern that follows.
The mechanism is worth understanding, because it explains why a clean-looking certificate can still be a problem. Endotoxins are fragments of the outer membrane of gram-negative bacteria. They are heat stable, which means the process that kills the bacteria does not necessarily destroy them, and they provoke a fever response when injected. That is why the regulator's guidance treats bacterial endotoxins testing as its own discipline with its own methods rather than something covered by a general purity number [2].
What identity and purity testing does not cover
This is the single most useful thing to carry away from this page, and it applies whichever format you choose.
- Mass spectrometry answers what the molecule is. It confirms the vial contains nicotinamide adenine dinucleotide rather than something else.
- HPLC answers what share of the contents is that molecule, reported as a purity percentage.
- Neither one looks for bacterial endotoxin. It is a separate assay, usually reported as a bacterial endotoxins or LAL result, and it is reported in its own units.
So a certificate of analysis showing 99% purity and a clean mass spectrum has answered two questions and not the one that produced the adverse event reports above. A seller who publishes both those assays and nothing else is not hiding anything, but they have not tested for the thing that matters most in an injectable. Asking for it is a normal request, and the answer, including a refusal, tells you a lot.
The questions that separate a supplier from a repackager
You cannot inspect a facility, but you can read what a seller publishes and notice what is missing. The list is short:
- Is the material described as pharmaceutical grade, or as food grade? Food grade is the failure mode the FDA named by name.
- Is there a certificate of analysis tied to the specific lot on the vial you receive, rather than a generic sample document?
- Does that certificate name a bacterial endotoxin or LAL result, or does it stop at identity and purity?
- Is there more than one testing laboratory behind the batch, and are they named?
- Does the listing state the quantity in grams, the lot, and the storage conditions, rather than only a price?
- Does the seller make human-use claims? A seller who tells you how to inject it is telling you they are outside the frame they claim to be selling inside.
For the legitimate side of the market the same instinct is written into the rules. Bulk drug substances used in compounding under section 503A must be accompanied by a valid certificate of analysis and must have been manufactured by an establishment registered with the FDA, and the agency's own advice to compounders is to know your bulk supplier [3]. NAD is currently listed by FDA in category 1 of the nominated bulk substances, meaning under evaluation. That is not approval, it is an interim position pending evaluation, and our NAD+ without prescription page sets out exactly what it does and does not permit.
What this page will not give you
No dosing, no volumes, no rates, no technique. This site does not publish administration instructions for a substance sold for laboratory research, and the buy-intent question does not require them. If your reason for reading was to work out how much to use, that is the point at which a clinician belongs in the conversation rather than a search result.
The vial on the card above is sold as laboratory research material and not for human consumption, which is the frame the entire research market operates in. We earn a commission if you use that link, which is disclosed on the card and in our disclaimer.
Questions about buying NAD+ injectable material
- Can I buy NAD+ injection material without a prescription?
- Research-grade NAD+ is sold openly for laboratory use rather than human use, so no prescription is involved in that transaction. A compounded, finished injectable dispensed for a person is a different product on a different legal footing, and that route does involve a prescriber.
- Is it better to buy NAD+ IV bags or a vial?
- They are not interchangeable objects. A finished IV product has been prepared by somebody who took responsibility for its sterility. A research vial of powder has not. The format question is really a question about who did that work.
- What should the certificate of analysis show for an injectable?
- Identity, purity, the lot number matching the vial you were sent, and a bacterial endotoxin or LAL result. Identity and purity alone leave the endotoxin question open, and that is the failure mode the FDA reported adverse events for.
- Why does the FDA mention food grade specifically?
- Because it found compounders using food-grade NAD+ from repackagers to make intravenous products. Food-grade material is not made to the contamination limits an injectable requires, and the agency linked the resulting reactions to excessive endotoxin levels.
- I felt chills and vomiting after an NAD+ shot. What is that?
- It matches the pattern the FDA described in its notice, and it can require medical treatment. Seek care rather than advice, and take the vial, lot number and seller details with you.
- Does a higher price mean a safer injectable?
- No. Price tracks channel rather than quality. A clinic session costs a large multiple of a vial because it includes staff, facility and oversight, and none of that guarantees the incoming material was pharmaceutical grade. Ask about the source and the testing instead.
The short version
Buying NAD+ injection material is a choice between a finished product someone is accountable for and a research powder nobody is accountable for. The FDA has already documented what goes wrong at the loose end of that market, and the failure is endotoxin rather than identity. Whatever route you take, the certificate for your lot should name an endotoxin result, the material should be described as pharmaceutical grade rather than food grade, and any seller telling you how to inject it has stepped outside the frame they are selling within. The same gap opens the other way with nasal formats, where nobody certifies the Semax bottle and the supplier that does publish certificates sells a vial instead. For the wider sourcing checklist, see where to buy NAD+, and for the arithmetic, the NAD+ price page.
References
- FDA, FDA reminds compounders to use ingredients suitable for sterile compounding
- FDA, Pyrogen and Endotoxins Testing: Questions and Answers
- FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act
- Gallagher C, Emmanuel OO, NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review, Ageing Research Reviews 2026